Clinical Study Of Migraine Evolution

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Migraine Headache

Study type: Observational

Funder types: Industry

Identifiers

NCT00460005

S2W106188

Details and patient eligibility

About

Understanding the speed at which migraine headaches develop is of importance to patients. Determining the proportions in which different headache pain build-up occurs, may provide health care practitioners with valuable information with which to prescribe the most appropriate treatment. Patients who experience a slow pain build-up may gain more benefit from medications which have a slow onset of effect, high tolerability and long action. Conversely, medications with a rapid onset of effect may be of greater benefit to patients who experience rapid onset of migraine pain.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subject is outpatient.
• Subject has a diagnosis of migraine with/without aura according to IHS criteria, of at least 1 years duration.
• Subject is able to comprehend the study procedures and to comply with study requirements.

Exclusion criteria

• Subject has other chronic pain condition(s) not associated with migraine
• Subject is unable to understand the schedule/questionnaire.